This report analyzes the disruptive themes that have driven M&A activity in 2021 in the Medical devices Sector
Global M&A activity in medical devices sector in 2021 grew 76% to reach $246 billion. In terms of deal volume, 2021 saw 860 deals compared to 657 in the previous year, recording a growth of 31%. There were 40 billion-dollar-plus M&A deals in the medical devices sector in 2021, compared to 16 in the previous year. In vitro diagnostics, diagnostic imaging and dental devices were the top three sectors and recorded the highest deal value in 2021.
Global M&A activity in medical devices sector in 2021 grew 76% to reach $246 billion. In terms of deal volume, 2021 saw 860 deals compared to 657 in the previous year, recording a growth of 31%. There were 40 billion-dollar-plus M&A deals in the medical devices sector in 2021, compared to 16 in the previous year. In vitro diagnostics, diagnostic imaging and dental devices were the top three sectors and recorded the highest deal value in 2021.
Scope
- This report provides an overview of merger and acquisition activity globally in 2021 in Medical Devices Sector
- It identifies the themes driving most notable to deals announced in 2021 in the Medical Devices Sector
Reasons to Buy
- Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
- In this report we have listed down the most notable deals in Medical Devices sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Table of Contents
- Global M&A deals in 2021 - Key takeaways
- Review of global M&A deals in 2021
- Themes driving global M&A deals in 2021
- Appendices
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Quidel
- Oracle
- Hellman & Friedman
- Bain Capital
- The Cooper Companies
- Coloplast
- United Surgical Partners
- Tenet Healthcare
- GE Healthcare
- ICU Medical
- Baxter International
- Medtronic
- Tecan Group
- DiaSorin
- ICON
- Steris
- OptumInsight
- Ortho Clinical Diagnostics
- Cerner
- athenahealth
- Generate Life Sciences
- Atos Medical
- SurgCenter Development
- Baylis Medical Company
- BK Medical Systems
- Smiths Group IntersectENT
- Paramit
- Luminex
- Lumenis
- PRA Health Sciences
- Cantel Medical
- Change Healthcare
- Advent International
- Lightbeam Health Solutions
- Royal Philips
- Integrated Media Technology
- Zoll Medical
- Stryker
- Inventive Health
- Nano-X Imaging
- HeartFlow
- BICO Group
- DarioHealth
- Advanced Human Imaging
- Vicarious Surgical
- Telus Health
- Hill-Rom Holdings
- Boston Scientific
- Iodine Software
- Epharmix
- Cardiologs Technologies
- Magnum International
- Itamar Medical
- Gauss Surgical
- Virusight
- USARAD and Medical Diagnostics Web
- Zebra Medical Vision
- Longview Acquisition
- Veris Health
- Visikol
- PsyInnovations
- PhysiMax Technologies
- D8 Holdings
- Babylon Healthcare
- EarlySense
- Preventice
- Laboratory Corp of America
- BioNano Genomics
- Mesa Laboratories
- Hibercell
- EQT Partners
- Pacific Biosciences of California
- Charles River Laboratories
- NeoGenomics
- InVitae
- F. Hoffmann-La Roche
- Bio-Techne
- Hologic
- Sema4
- 23andMe
- Veracyte
- Thermo Fisher Scientific
- PerkinElmer
- Personal Genome Diagnostics
- Lemonaid Health
- BioDiscovery
- Agena Bioscience
- Genuity Science
- Lifebrain
- Omniome
- HalioDx
- Vigene Biosciences
- Immunodiagnostic Systems
- Inivata
- Genosity
- GenMark Diagnostics
- Asuragen
- Diagenode
- CM Life Sciences
- VG Acquisition
- Decipher Biosciences
- Mesa Biotech
- Oxford Immunotec
